Zobrazeno 1 - 10 of 23 pro vyhledávání: '"Jørn Starklint"'
1
Use of statins and risk of myeloproliferative neoplasms - a Danish nationwide case-control study
Autor: Daniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Lasse H. Jakobsen, Marianne Tang Severinsen, Louise Hur Hannig, Jørn Starklint, Morten Hagemann Hilsøe, Anders Pommer Vallentin, Mette Brabrand, Hans Carl Hasselbalch, Tarec C. El-Galaly, Anne Stidsholt Roug
Publikováno v: Kristensen, D T, Øvlisen, A K, Jakobsen, L H, Severinsen, M T, Hannig, L H, Starklint, J, Hilsøe, M H, Vallentin, A P, Brabrand, M, Hasselbalch, H C, El-Galaly, T C & Roug, A S 2023, ' Use of statins and risk of myeloproliferative neoplasms-a Danish nationwide case-control study ', Blood advances . https://doi.org/10.1182/bloodadvances.2023009784
Previous studies have indicated a possible cancer protective effect of statins in solid cancers; however, this has never been investigated for myeloproliferative neoplasms (MPNs). We aimed to investigate the association between statin use and risk of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92d4822709b3ff9d79f993bab49721e6
https://vbn.aau.dk/da/publications/4e982bb8-9728-4fa8-85a9-ec096a63692e
Zobrazit plný text záznamu
2
Healthcare resource utilization in patients with myeloproliferative neoplasms: A Danish nationwide matched cohort study
Autor: Sarah Friis Christensen, Lise Skovgaard Svingel, Anders Kjærsgaard, Anna Stenling, Bianka Darvalics, Björn Paulsson, Christen Lykkegaard Andersen, Christian Fynbo Christiansen, Jesper Stentoft, Jørn Starklint, Marianne Tang Severinsen, Mette Borg Clausen, Morten Hagemann Hilsøe, Hans Carl Hasselbalch, Henrik Frederiksen, Ellen Margrethe Mikkelsen, Marie Bak
Publikováno v: Christensen, S F, Svingel, L S, Kjærsgaard, A, Stenling, A, Darvalics, B, Paulsson, B, Andersen, C L, Christiansen, C F, Stentoft, J, Starklint, J, Severinsen, M T, Clausen, M B, Hilsøe, M H, Hasselbalch, H C, Frederiksen, H, Mikkelsen, E M & Bak, M 2022, ' Healthcare resource utilization in patients with myeloproliferative neoplasms : A Danish nationwide matched cohort study ', European Journal of Haematology, vol. 109, no. 5, pp. 526-541 . https://doi.org/10.1111/ejh.13841
Christensen, S F, Svingel, L S, Kjærsgaard, A, Stenling, A, Darvalics, B, Paulsson, B, Andersen, C L, Christiansen, C F, Stentoft, J, Starklint, J, Severinsen, M T, Clausen, M B, Hilsøe, M H, Hasselbalch, H C, Frederiksen, H, Mikkelsen, E M & Bak, M 2022, ' Healthcare Resource Utilization in Patients with Myeloproliferative Neoplasms : A Danish Nationwide Matched Cohort Study ', European Journal of Haematology, vol. 109, no. 5, pp. 526-541 . https://doi.org/10.1111/ejh.13841
Christensen, S F, Svingel, L S, Kjaersgaard, A, Stenling, A, Darvalics, B, Paulsson, B, Andersen, C L, Christiansen, C F, Stentoft, J, Starklint, J, Severinsen, M T, Clausen, M B, Hilsoe, M H, Hasselbalch, H C, Frederiksen, H, Mikkelsen, E M & Bak, M 2022, ' Healthcare resource utilization in patients with myeloproliferative neoplasms : A Danish nationwide matched cohort study ', European Journal of Haematology, vol. 109, no. 5, pp. 526-541 . https://doi.org/10.1111/ejh.13841
Few studies have assessed healthcare resource utilization (HRU) in patients with Philadelphia-negative myeloproliferative neoplasms (MPN) using a matched cohort design. Further, no detailed assessment of HRU in the years preceding an MPN diagnosis ex
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66d298be2a0986ff9375ffab74353ed6
https://pubmed.ncbi.nlm.nih.gov/35900040
Zobrazit plný text záznamu
4
HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: A NATIONWIDE MATCHED COHORT STUDY
Autor: Christensen, S., Lise Skovgaard Svingel, Kjærsgaard, A., Stenling, A., Bianca Darvalics, Paulsson, B., Andersen, C., Christiansen, C., Hasselbalch, H., Stentoft, J., Jørn Starklint, Marianne Tang Severinsen, Clausen, M., Morten Hagemann Hilsøe, Henrik Frederiksen, Mikkelsen, E., Bak, M.
Publikováno v: Christensen, S, Svingel, L S, Kjærsgaard, A, Stenling, A, Darvalics, B, Paulsson, B, Andersen, C, Christiansen, C, Hasselbalch, H, Stentoft, J, Starklint, J, Severinsen, M T, Clausen, M, Hagemann Hilsøe, M, Frederiksen, H, Mikkelsen, E & Bak, M 2021, ' HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: A NATIONWIDE MATCHED COHORT STUDY ', European Hematology Association Congress 2021 (EHA), 09/06/2021-12/06/2021 .
Christensen, S, Svingel, L S, Kjærsgaard, A, Stenling, A, Darvalics, B, Paulsson, B, Andersen, C, Christiansen, C, Hasselbalch, H, Stentoft, J, Starklint, J, Severinsen, M T, Clausen, M, Hagemann Hilsøe, M, Frederiksen, H, Mikkelsen, E & Bak, M 2021, ' HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: A NATIONWIDE MATCHED COHORT STUDY ', HemaSphere, vol. 5, no. S2, EP1107, pp. 529-530 . < https://journals.lww.com/hemasphere/Citation/2021/06002/EHA2021_Virtual_Congress_Abstract_Book.1.aspx >
University of Southern Denmark
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::367abad34a21740fd91f6d4669fc400b
https://portal.findresearcher.sdu.dk/da/publications/9c2bb450-3d67-4e79-a949-239d231fdd0e
Zobrazit plný text záznamu
5
No differential overall or relative survival effect of rituximab in male and female patients with diffuse large B-cell lymphoma: a Danish population-based study of 3783 patients
Autor: Judit Jørgensen, Martin Bøgsted, Michael Roost Clausen, Jorne Lionel Biccler, Marianne Tang Severinsen, Tarec Christoffer El-Galaly, Lasse Hjort Jakobsen, Jørn Starklint, Maja Bech Juul, Christian Bjørn Poulsen, Peter de Nully Brown, Pär Josefsson, Per Trøllund Pedersen
Publikováno v: Jakobsen, L H, Biccler, J L, Brown, P D N, Jørgensen, J M, Josefsson, P L, Poulsen, C B, Starklint, J, Clausen, M R, Pedersen, P T, Juul, M B, Severinsen, M T, Bøgsted, M & El-Galaly, T C 2019, ' No differential overall or relative survival effect of rituximab in male and female patients with diffuse large B-cell lymphoma : a Danish population-based study of 3783 patients ', Leukemia and Lymphoma, vol. 60, no. 11, pp. 2798-2801 . https://doi.org/10.1080/10428194.2019.1602264
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddedd7a32706c92ea43b0138ebbf7a96
https://doi.org/10.1080/10428194.2019.1602264
Zobrazit plný text záznamu
6
Increased risk of osteoporosis following commonly used first-line treatments for lymphoma:a Danish Nationwide Cohort Study
Autor: Joachim Baech, Paw Jensen, Jørn Starklint, Steen Moeller Hansen, Henrik Frederiksen, Peter Vestergaard, Andreas Kiesbye Øvlisen, Tarec Christoffer El-Galaly, Pär Josefsson, Judit Jørgensen, Peter de Nully Brown, Lasse Hjort Jakobsen, Troels Hammer, Michael Roost Clausen, Christian Torp-Pedersen, Marianne Tang Severinsen
Publikováno v: Baech, J, Hansen, S M, Jakobsen, L H, Øvlisen, A K, Severinsen, M T, Brown, P D N, Vestergaard, P, Frederiksen, H, Jørgensen, J, Starklint, J, Josefsson, P, Hammer, T, Clausen, M R, Torp-Pedersen, C, Jensen, P & El-Galaly, T C 2020, ' Increased risk of osteoporosis following commonly used first-line treatments for lymphoma : a Danish Nationwide Cohort Study ', Leukemia and Lymphoma, vol. 61, no. 6, pp. 1345-1354 . https://doi.org/10.1080/10428194.2020.1723015
High-dose prednisolone is used in first-line treatment for lymphoma, but the potential adverse impact on bone health is unclear. Danish patients with diffuse large B-cell lymphoma or follicular lymphoma diagnosed between 2000 and 2012 were matched to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::879f61775f58f422105350e355d02535
https://portal.findresearcher.sdu.dk/da/publications/27653e77-fc10-40b3-a0b1-a238c2b7925c
Zobrazit plný text záznamu
7
Clinical prognostic scores are poor predictors of overall survival in various types of malignant lymphomas
Autor: Tarec Christoffer El-Galaly, Jacob Haaber Christensen, Pär Josefsson, Lasse Hjort Jakobsen, Jorne Lionel Biccler, Andriette Dessau, Christian Bjørn Poulsen, Judit Jørgensen, Maja Bech Juul, Jørn Starklint, Peter de Nully Brown, Martin Bøgsted
Publikováno v: Biccler, J L, El-Galaly, T C, Bøgsted, M, Jørgensen, J, de Nully Brown, P, Poulsen, C B, Starklint, J, Juul, M B, Christensen, J H, Josefsson, P, Dessau, A & Jakobsen, L H 2019, ' Clinical prognostic scores are poor predictors of overall survival in various types of malignant lymphomas ', Leukemia and Lymphoma, vol. 60, no. 6, pp. 1580–1583 . https://doi.org/10.1080/10428194.2018.1540044
Biccler, J L, El-Galaly, T C, Bøgsted, M, Jørgensen, J, de Nully Brown, P, Poulsen, C B, Starklint, J, Juul, M B, Christensen, J H, Josefsson, P, Dessau, A & Jakobsen, L H 2019, ' Clinical prognostic scores are poor predictors of overall survival in various types of malignant lymphomas ', Leukemia and Lymphoma, vol. 60, no. 6, pp. 1580-1583 . https://doi.org/10.1080/10428194.2018.1540044
Malignant lymphomas comprise a heterogeneous group of diseases with important differences in pathogenesis, management strategies, and outcome [1]. To obtain information about prognosis in daily pra...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c0d6c197abe24e803ff91a3c6324e2b
https://doi.org/10.1080/10428194.2018.1540044
Zobrazit plný text záznamu
8
Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial - a Randomized Controlled Phase III Clinical Trial
Autor: Mads Thomassen, Jesper Stentoft, Hans Carl Hasselbalch, Thomas Stauffer Larsen, Ole Weis Bjerrum, Marianne Tang Severinsen, Mette Brabrand, Vibe Skov, Lukas Frans Ocias, Thomas Kielsgaard Kristensen, Torben Mourits-Andersen, Ulrik Malthe Overgaard, Mikael Frederiksen, Trine Alma Knudsen, Dennis Lund Hansen, Torben A Kruse, Lasse Kjær, Peter Møller, Daniel El Fassi, Jørn Starklint, Karin de Stricker
Publikováno v: Knudsen, T A, Hansen, D L, Ocias, L F, Bjerrum, O W, Brabrand, M, El Fassi, D, Frederiksen, M, Kjaer, L, Kristensen, T K, Kruse, T A, Mourits-Andersen, T, Moller, P, Overgaard, U M, Severinsen, M T, Skov, V, Stentoft, J, Starklint, J, de Stricker, K, Thomassen, M, Larsen, T S & Hasselbalch, H C 2018, ' Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial-a Randomized Controlled Phase III Clinical Trial ', Blood, vol. 132, no. 1 . https://doi.org/10.1182/blood-2018-99-111255
Knudsen, T A, Hansen, D L, Ocias, L F, Bjerrum, O W, Brabrand, M, El Fassi, D, Frederiksen, M, Kjær, L, Kristensen, T K, Kruse, T A, Mourits-Andersen, T, Møller, P, Overgaard, U M, Severinsen, M T, Skov, V, Stentoft, J, Starklint, J, de Stricker, K, Thomassen, M, Larsen, T S & Hasselbalch, H C 2018, ' Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera : Preliminary Results from the Three-Year Analysis of the Daliah Trial-a Randomized Controlled Phase III Clinical Trial ', Blood, vol. 132, no. Suppl 1, pp. 580 . https://doi.org/10.1182/blood-2018-99-111255
Background Recombinant Interferon Alpha-2a (r-IFNα) is a potent immunomodulating agent, which has been used off-label for the treatment of polycythemia vera (PV) for more than three decades and has been demonstrated to induce high rates of clinical,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd40781d5cd616e581043ece0f569001
https://portal.findresearcher.sdu.dk/da/publications/e3179d20-b94b-4c83-9ed2-31301298e4e6
Zobrazit plný text záznamu
9
Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines
Autor: Christian Bjørn Poulsen, Joachim Baech, Steen Møller Hansen, Jacob Haaber, Judit Jørgensen, Christian Torp-Pedersen, P Soegaard, Maja Bech Juul, Peter Enemark Lund, Pär Josefsson, Jørn Starklint, Tarec Christoffer El-Galaly, Peter de Nully Brown
Publikováno v: Baech, J, Hansen, S M, Lund, P E, Søgaard, P, Brown, P D N, Haaber, J, Jørgensen, J, Starklint, J, Josefsson, P, Poulsen, C B, Juul, M B, Torp-Pedersen, C & El-Galaly, T C 2018, ' Cumulative anthracycline exposure and risk of cardiotoxicity : a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines ', British Journal of Haematology, vol. 183, no. 5, pp. 717-726 . https://doi.org/10.1111/bjh.15603
Baech, J, Hansen, S M, Lund, P E, Soegaard, P, Brown, P D N, Haaber, J, Jørgensen, J, Starklint, J, Josefsson, P, Poulsen, C B, Juul, M B, Torp-Pedersen, C & El-Galaly, T C 2018, ' Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines ', British Journal of Haematology, vol. 183, no. 5, pp. 717-726 . https://doi.org/10.1111/bjh.15603
Cardiotoxicity is a known risk of anthracycline treatment. However, the relative contribution of anthracyclines to the development of congestive heart failure (CHF), when included in a poly-chemotherapy regimen, is unclear. We examined cardiotoxicity
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cc0500066b61318e5ab0dcaa0e75b55
https://pubmed.ncbi.nlm.nih.gov/32103505
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje